Table 1.
Participant characteristics by MDC usage
| Characteristic | All users (N = 2517) | High usage (n = 1223) | Moderate usage (n = 626) | Low usage (n = 668) |
|---|---|---|---|---|
| Percentage of all users, % | 100 | 48.6 | 24.9 | 26.5 |
| Age in years | ||||
| Mean (SD) | 52.8 (13.4) | 53.1 (13.6) | 52.0 (13.7) | 53.3 (12.8) |
| Median (IQR) | 54 (18) | 54 (17) | 53 (19) | 54 (17) |
| Age groupa, n (%) | ||||
| ≤25 | 65 (2.6) | 29 (2.4) | 21 (3.4) | 15 (2.2) |
| 26–49 | 864 (34.3) | 424 (34.7) | 222 (35.5) | 218 (32.6) |
| 50–64 | 1109 (44.1) | 531 (43.4) | 267 (42.7) | 311 (46.6) |
| ≥65 | 478 (19.0) | 238 (19.5) | 116 (18.5) | 124 (18.6) |
| Male sex, n (%) | 1380 (54.8) | 679 (55.5) | 333 (53.2) | 368 (55.1) |
| Weight in kgb, n (%) | ||||
| ≤60 | 582 (23.1) | 252 (20.6) | 155 (24.8) | 175 (26.2) |
| 61–70 | 727 (28.9) | 333 (27.2) | 184 (29.4) | 210 (31.4) |
| 71–80 | 620 (24.6) | 313 (25.6) | 143 (22.8) | 164 (24.6) |
| 81–90 | 350 (13.9) | 176 (14.4) | 94 (15.0) | 80 (12.0) |
| 91–100 | 146 (5.8) | 81 (6.6) | 34 (5.4) | 31 (4.6) |
| >100 | 81 (3.2) | 59 (4.8) | 14 (2.2) | 8 (1.2) |
| Medication usec | ||||
| Insulin glargine 100 IU/ml | 1485 (59.0) | 651 (53.2) | 412 (65.8) | 422 (63.2) |
| Insulin glargine 300 IU/ml | 1031 (41.0) | 571 (46.7) | 214 (34.2) | 246 (36.8) |
| Titration duration, days | ||||
| Mean (SD) | 43.3 (49.9) | 19.7 (26.2) | 46.6 (47.7) | 83.4 (58.1) |
| Median (IQR) | 28 (46) | 11 (23) | 28 (38) | 72 (77) |
IU international units, IQR interquartile range, SD standard deviation
aAge data not available for one participant
bWeight data not available for 11 participants
cOne participant received insulin degludec 100 U/ml